Serious bacterial infections require rapid, accurate treatment, yet conventional antimicrobial susceptibility testing takes up to 24 hours to identify the most effective antibiotic. During this time, patients are typically treated with broad-spectrum antibiotics.
To address this, SGH pharmacists developed a rapid flow cytometry method that analyses how bacteria respond to antibiotics in under an hour. The study showed more than 90% accuracy in identifying antibiotic susceptibility for carbapenem-resistant bacteria while detecting resistant subpopulations that traditional testing may miss.
Beyond reducing testing time, the innovation helps clinicians make more informed choices. The team hopes it will strengthen antimicrobial stewardship, improve outcomes for patients with life-threatening infections and advance infection care.
This article was first published on 5 February 2025.